South Carolina Cancer Health Equity Consortium (SC CHEC): Summer Undergraduate Research Training Program

 描述(由申请人提供)：南卡罗来纳医科大学(MUSC)、南卡罗来纳大学(USC)和三所历史上的黑人学院/大学-克拉夫林大学(CU)、南卡罗来纳州立大学(SCSU)和沃里斯学院(VC)-在南卡罗来纳州癌症健康公平联盟(SC CHEC)的更大支持下，联手为R25E NIH/NCI癌症教育补助金计划开发这一申请。这些机构共同创建了一个创新的、跨机构的、为期14周的暑期课程。这与由美国一些领先的癌症研究人员提供的动手实验室研究培训平台和职业指导相结合，以吸引和催化新一代多样化的生物医学科学家。在这项为期五年的新计划中，来自南加州大学、加州大学、南加州大学和弗吉尼亚大学的80名本科生大三和大四学生(被指定为SC CHEC学生研究员)将与美国国家癌症研究所(NCI)指定的癌症中心MUSC Holling癌症中心的研究人员互动，让他们了解跨越基础、临床和人口科学的生物医学研究的最新进展，重点是南卡罗来纳州(SC)的癌症差异动态。这一新计划的课程和培训侧重于SC中发病率、发病率和死亡率差异最大的四种癌症--乳腺癌、前列腺癌、头颈部癌和宫颈癌。被诊断为这四种癌症的患者的健康结果受到种族、民族、城乡居民、社会经济地位以及潜在的生物学因素的强烈影响。这项R25E计划的主要战略将在南加州大学癌症研究的当代科学方法的背景下，采用面对面的课堂和实验室教学。这些将由选定的以临床和生物技术为重点的轮换、社区参与和研究生入学考试准备来补充。SC Check领导层坚信，促进千禧一代(90后)对癌症生物医学和生物行为研究的兴趣、职业发展和承诺是实现SC及以后健康公平和改善健康结果的关键一步。

 DESCRIPTION (provided by applicant): The Medical University of South Carolina (MUSC), the University of South Carolina (USC), and three historically black colleges/universities - Claflin University (CU), South Carolina State University (SCSU), and Voorhees College (VC) - have joined forces under the larger aegis of the South Carolina Cancer Health Equity Consortium (SC CHEC) to develop this application for an R25E NIH/NCI Cancer Education Grants Program. Together, these institutions have created an innovative, inter-institutional, 14-week summer course. This is combined with a hands-on laboratory research training platform and career mentoring by some of the nation's leading cancer researchers to attract and catalyze a new generation of diverse biomedical scientists. Within this new five-year initiative, 80 undergraduate juniors and seniors (designated as SC CHEC Student Fellows) from USC, CU, SCSU, and VC will engage with investigators at the MUSC Hollings Cancer Center, a National Cancer Institute (NCI) designated cancer center, to expose them to the latest advances in biomedical research spanning basic, clinical, and population sciences with an emphasis on cancer disparity dynamics in South Carolina (SC). The curriculum and training of this new initiative are focused on four of the most disparate cancers in terms of incidence, morbidity, and mortality in SC - breast, prostate, head/neck, and cervical cancer. Health outcomes for patients diagnosed with these four cancers are strongly influenced by race, ethnicity, urban/rural residence, socioeconomic position, and potentially biology. This R25E program's primary strategy will employ in-person classroom and laboratory instruction within the context of contemporary scientific approaches to cancer research at MUSC. These will be complemented by selected clinical and biotechnology-focused rotations, community engagement, and Graduate Record Examination preparation. The SC CHEC leadership strongly believes that promoting interest, career development, and commitment from the Millennial Generation (those born in the 1990s) to cancer biomedical and biobehavioral research is a critical step to attaining health equity and improved health outcomes in SC and beyond.